2.57 USD
-0.01 (-0.39%)
2.55 USD
-0.02 (-0.78%)
Overall GDRX gets a fundamental rating of 6 out of 10. We evaluated GDRX against 35 industry peers in the Health Care Technology industry. GDRX has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on GDRX. This makes GDRX very considerable for value investing!
1. Profitability
1.1 Basic Checks
- GDRX had positive earnings in the past year.
- In the past year GDRX had a positive cash flow from operations.
- In the past 5 years GDRX reported 4 times negative net income.
- In the past 5 years GDRX always reported a positive cash flow from operatings.
1.2 Ratios
- GDRX's Return On Assets of 2.40% is amongst the best of the industry. GDRX outperforms 85.71% of its industry peers.
- Looking at the Return On Equity, with a value of 5.29%, GDRX belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 5.73%, GDRX belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROIC | 5.73% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of GDRX (3.97%) is better than 88.57% of its industry peers.
- GDRX's Profit Margin has declined in the last couple of years.
- With an excellent Operating Margin value of 10.37%, GDRX belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
- GDRX's Operating Margin has declined in the last couple of years.
- GDRX has a better Gross Margin (93.46%) than 100.00% of its industry peers.
- GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GDRX is destroying value.
- The number of shares outstanding for GDRX has been reduced compared to 1 year ago.
- Compared to 5 years ago, GDRX has about the same amount of shares outstanding.
- Compared to 1 year ago, GDRX has an improved debt to assets ratio.
2.2 Solvency
- GDRX has an Altman-Z score of 0.39. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
- GDRX has a Altman-Z score (0.39) which is in line with its industry peers.
- The Debt to FCF ratio of GDRX is 4.66, which is a neutral value as it means it would take GDRX, 4.66 years of fcf income to pay off all of its debts.
- GDRX has a Debt to FCF ratio of 4.66. This is comparable to the rest of the industry: GDRX outperforms 60.00% of its industry peers.
- A Debt/Equity ratio of 0.81 indicates that GDRX is somewhat dependend on debt financing.
- GDRX has a worse Debt to Equity ratio (0.81) than 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Altman-Z | 0.39 |
ROIC/WACC0.54
WACC10.55%
2.3 Liquidity
- GDRX has a Current Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
- GDRX has a better Current ratio (3.11) than 62.86% of its industry peers.
- GDRX has a Quick Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
- The Quick ratio of GDRX (3.11) is better than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 |
3. Growth
3.1 Past
- GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.37%, which is quite good.
- Measured over the past years, GDRX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.47% on average per year.
- Looking at the last year, GDRX shows a small growth in Revenue. The Revenue has grown by 1.30% in the last year.
- Measured over the past years, GDRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
3.2 Future
- The Earnings Per Share is expected to grow by 25.32% on average over the next years. This is a very strong growth
- GDRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.00% yearly.
EPS Next Y11.45%
EPS Next 2Y15.72%
EPS Next 3Y16.53%
EPS Next 5Y25.32%
Revenue Next Year0.14%
Revenue Next 2Y1.37%
Revenue Next 3Y3.29%
Revenue Next 5Y5%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 7.34, the valuation of GDRX can be described as very cheap.
- Based on the Price/Earnings ratio, GDRX is valued cheaper than 100.00% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.32. GDRX is valued rather cheaply when compared to this.
- GDRX is valuated cheaply with a Price/Forward Earnings ratio of 5.82.
- Based on the Price/Forward Earnings ratio, GDRX is valued cheaper than 100.00% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.32. GDRX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.34 | ||
| Fwd PE | 5.82 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GDRX is valued cheaply inside the industry as 94.29% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 91.43% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.31 | ||
| EV/EBITDA | 6.65 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of GDRX may justify a higher PE ratio.
- A more expensive valuation may be justified as GDRX's earnings are expected to grow with 16.53% in the coming years.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y15.72%
EPS Next 3Y16.53%
5. Dividend
5.1 Amount
- No dividends for GDRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.57
-0.01 (-0.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners50.75%
Inst Owner Change0.09%
Ins Owners11.19%
Ins Owner Change10.68%
Market Cap872.34M
Revenue(TTM)800.65M
Net Income(TTM)31.75M
Analysts74.29
Price Target4.83 (87.94%)
Short Float %9.77%
Short Ratio3.9
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.02%
Min EPS beat(2)-13.38%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.95%
Min EPS beat(4)-13.38%
Max EPS beat(4)-7.12%
EPS beat(8)2
Avg EPS beat(8)-4.79%
EPS beat(12)6
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)11.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.22%
Revenue beat(8)0
Avg Revenue beat(8)-1.92%
Revenue beat(12)1
Avg Revenue beat(12)-1.83%
Revenue beat(16)2
Avg Revenue beat(16)-1.59%
PT rev (1m)-6.88%
PT rev (3m)-10.9%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.06%
EPS NY rev (1m)0.19%
EPS NY rev (3m)-3.54%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.51%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.34 | ||
| Fwd PE | 5.82 | ||
| P/S | 1.09 | ||
| P/FCF | 8.31 | ||
| P/OCF | 4.85 | ||
| P/B | 1.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.65 |
EPS(TTM)0.35
EY13.62%
EPS(NY)0.44
Fwd EY17.2%
FCF(TTM)0.31
FCFY12.03%
OCF(TTM)0.53
OCFY20.61%
SpS2.36
BVpS1.77
TBVpS-0.08
PEG (NY)0.64
PEG (5Y)N/A
Graham Number3.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROCE | 7.26% | ||
| ROIC | 5.73% | ||
| ROICexc | 7.53% | ||
| ROICexgc | 26.92% | ||
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% | ||
| FCFM | 13.11% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y37.95%
ROICexgc growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score6
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Debt/EBITDA | 2.95 | ||
| Cap/Depr | 92.2% | ||
| Cap/Sales | 9.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 109.5% | ||
| Profit Quality | 330.43% | ||
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 | ||
| Altman-Z | 0.39 |
F-Score6
WACC10.55%
ROIC/WACC0.54
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
EPS Next Y11.45%
EPS Next 2Y15.72%
EPS Next 3Y16.53%
EPS Next 5Y25.32%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
Revenue Next Year0.14%
Revenue Next 2Y1.37%
Revenue Next 3Y3.29%
Revenue Next 5Y5%
EBIT growth 1Y179.68%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year34.43%
EBIT Next 3Y15.99%
EBIT Next 5Y13.87%
FCF growth 1Y9.18%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y16.5%
OCF growth 3Y0.94%
OCF growth 5Y17.16%
GOODRX HOLDINGS INC-CLASS A / GDRX FAQ
Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?
ChartMill assigns a fundamental rating of 6 / 10 to GDRX.
What is the valuation status for GDRX stock?
ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.
What is the profitability of GDRX stock?
GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 6 / 10.
What is the earnings growth outlook for GOODRX HOLDINGS INC-CLASS A?
The Earnings per Share (EPS) of GOODRX HOLDINGS INC-CLASS A (GDRX) is expected to grow by 11.45% in the next year.